Can Breast Cancer Biopsy Influence Sentinel Lymph Node Status?

Giuliani, Michela; Patrolecco, Federica; Rella, Rossella; Giovanni, Silvia Eleonora Di; Infante, Amato; Romani, Malika; Mulè, Antonino; Arciuolo, Damiano; Belli, Paolo; Bonomo, Lorenzo

doi:10.1016/j.clbc.2016.06.005

Cited by 4 publications

(3 citation statements)

References 50 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…For cases with complete remission after neoadjuvant systemic therapy, CNB can be the only method that reflects the characteristics of the tumor (4)(5)(6). On the other hand, CNB is a useful tool for the diagnosis and management of sentinel lymph node metastasis (7) and distant metastasis (8). In addition to its diagnostic and predictive role in breast cancer, CNB is used to support patients' education, cooperation, and consent (9).…”

Section: Introductionmentioning

confidence: 99%

Concordance of immunohistochemistry between core needle biopsy and surgical resection of breast cancer

Kombak¹,

Şahin²,

Hande³

et al. 2017

Turk J Med Sci

View full text Add to dashboard Cite

Background/aim: The purpose of this study was to evaluate the concordance of immunohistochemical (IHC) parameters of breast lesions between the core needle biopsy (CNB) and the surgical resection specimen.Materials and methods: CNB and resection specimens of female patients were retrospectively analyzed. ER, PR, HER-2, and Ki-67 parameters were compared for each patient. A total of 284 cases were assessed. Forty-one and 48 cases were excluded from the HER-2 and Ki-67 examinations, respectively, because the CNBs did not allow for IHC.Results: Concordance rates were 93.3% for ER, 89.4% for PR, 90.1% for HER-2, and 80.9% for Ki-67. Conclusion:CNB is accurate for the evaluation of the surrogate molecular profile of invasive breast cancer despite the heterogeneity of tumors.

show abstract

Section: Introductionmentioning

confidence: 99%

Concordance of immunohistochemistry between core needle biopsy and surgical resection of breast cancer

Kombak¹,

Şahin²,

Hande³

et al. 2017

Turk J Med Sci

View full text Add to dashboard Cite

show abstract

“…More significantly, the small sample size should only characterize these findings as "hypothesis-generating", for which a larger study of CNB should be conducted in early-stage breast cancer given the widespread use of CNB and the importance of the issue to breast cancer patients and their providers. Some publications suggest that the risks of needle tract seeding and cell dissemination are related to the diameter or gauge of the needle biopsy device [36][37][38]. However, due to the heterogeneous design of most studies and their general lack of controls, it is difficult to prove a definitive association between biopsy device diameter and tumor cell displacement.…”

Section: Discussionmentioning

confidence: 99%

Reducing the Risk of Needle Tract Seeding or Tumor Cell Dissemination during Needle Biopsy Procedures

Holmes

2024

Cancers

View full text Add to dashboard Cite

Purpose: Many women fear that breast needle biopsies increase the risk of cancer spread. The purpose of this review article is to discuss the breast cancer literature regarding the risk of needle-biopsy-induced cancer cell displacement and its impact on local and regional recurrence and breast cancer survival. Methods: A literature review is performed to discuss the risks and mitigation of needle-biopsy-induced cancer cell displacement. Results: Needle-biopsy-induced cancer cell displacement is a common event. The risk is influenced by the biopsy technique and the breast cancer type. Evidence suggests that the risk of needle-biopsy-induced cancer cell displacement may potentially increase the odds of local recurrence but has no impact on regional recurrence and long-term survival. Conclusions: Technical modifications of needle biopsy procedures can reduce the risk of breast needle-biopsy-induced cancer cell displacement and potentially reduce the risk of local recurrence, especially in patients for whom whole breast radiation is to be omitted.

show abstract

“…Comfortingly, a core needle biopsy was performed before the prepared radical mastectomy. Ultrasound-guided core needle biopsy is a safe method with high sensitivity and specificity in the diagnosis of breast lesions [ 16 , 17 ]. The advantage of preoperative biopsy is that enough tissue can be obtained for immunohistochemical examination with minimal trauma.…”

Section: Discussionmentioning

confidence: 99%

Primary Breast Diffuse Large B-Cell Lymphoma in a 42-Year-Old Female: A Case Report and Review of Literature

Chen

Zhou

2021

J Med Cases

View full text Add to dashboard Cite

Primary breast diffuse large B-cell lymphoma (PB-DLBCL) is a rare localized extranodal lymphoma. It is mainly diagnosed by pathological examination due to the lack of specific clinical and imaging manifestations. Whole-body positron emission tomography-computed tomography (PET-CT) is widely used in determining clinical staging and guiding clinical treatment. As part of comprehensive treatment, targeted therapy with rituximab, intrathecal methotrexate injection and consolidation radiotherapy remain controversial in treating PB-DLBCL, but the comprehensive treatment based on full-course of chemotherapy is still widely used as the first-line treatment. Comprehensive treatment often leads to a sharp decline in the immunity of elderly patients with malignancy. In this situation, surgery may be a good chance to improve their life quality without serious complications. We present a rare case of PB-DLBCL during the coronavirus disease 2019 (COVID-19) pandemic. The patient underwent chest CT scan to screen COVID-19 and a mass of left breast was accidentally found. Because of the city lockdown policy in Wuhan, she did not seek medical help until noticing that the mass was gradually enlarged. Both ultrasonography and mammography indicated that the lesion was breast cancer. However, ultrasound-guided core needle biopsy revealed diffuse large B-cell lymphoma of breast and PET-CT scan showed that the lesion was a primary hypermetabolic tumor of left breast. The patient subsequently received comprehensive treatment based on six cycles of rituximab-cyclophosphamide, hydroxydaunomycin, oncovin, prednisone (R-CHOP) chemotherapy.

show abstract

Can Breast Cancer Biopsy Influence Sentinel Lymph Node Status?

Cited by 4 publications

References 50 publications

Concordance of immunohistochemistry between core needle biopsy and surgical resection of breast cancer

Concordance of immunohistochemistry between core needle biopsy and surgical resection of breast cancer

Reducing the Risk of Needle Tract Seeding or Tumor Cell Dissemination during Needle Biopsy Procedures

Primary Breast Diffuse Large B-Cell Lymphoma in a 42-Year-Old Female: A Case Report and Review of Literature

Contact Info

Product

Resources

About